SARS-CoV-2

Showing NaN - NaN of 14

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran

Recruiting
  • SARS-CoV-2
  • SPIKEVAX
  • New York, New York
    Aetion, Inc
Nov 8, 2023

SARS-CoV-2, Influenza Trial in Canada, United States (mRNA-1083, Placebo, Influenza Vaccine)

Not yet recruiting
  • SARS-CoV-2
  • Influenza
  • mRNA-1083
  • +3 more
  • Anniston, Alabama
  • +172 more
Oct 18, 2023

SARS-CoV-2 Trial in United States (mRNA-1273.211, mRNA-1273, mRNA-1273.617.2)

Active, not recruiting
  • SARS-CoV-2
  • mRNA-1273.211
  • +6 more
  • Sacramento, California
  • +22 more
Nov 16, 2022

SARS-CoV-2 Trial in Atlanta, Seattle (mRNA-1273)

Active, not recruiting
  • SARS-CoV-2
  • mRNA-1273
  • Mesa, Arizona
  • +14 more
Aug 31, 2022

COVID-19, SARS-CoV-2 Trial in Chile, Peru, United States (AZD1222, Placebo)

Active, not recruiting
  • COVID-19
  • SARS-CoV-2
  • AZD1222
  • Placebo
  • Phoenix, Arizona
  • +83 more
Jul 13, 2022

COVID-19 Vaccination and Breakthrough Infections Among Persons

Completed
  • Immunocompromised
  • +5 more
  • BNT162b2 (Tozinameran)
  • New York, New York
    Pfizer Inc.
Jul 1, 2022

SARS-CoV-2 Trial in New York (Sodium Chloride, NDV-HXP-S IN low dose, NDV-HXP-S IM low dose)

Recruiting
  • SARS-CoV-2
  • Sodium Chloride
  • +4 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jun 30, 2022

Compare mRNA-1273 Versus BNT162b2 COVID-19 Vaccines Among

Completed
  • SARS-CoV-2
    • New York, New York
      Aetion Inc.
    May 5, 2022

    COVID-19, SARS-CoV-2 Trial in Worldwide (Enoxaparin, Apixaban)

    Recruiting
    • COVID-19
    • SARS-CoV-2
    • New York, New York
    • +20 more
    Jan 18, 2022

    COVID-19, Corona Virus Infection, SARS (Severe Acute Respiratory Syndrome) Trial in United States (Hydroxychloroquine Sulfate,

    Completed
    • COVID-19
    • +3 more
    • Hydroxychloroquine Sulfate
    • Ascorbic Acid
    • Los Angeles, California
    • +7 more
    Dec 14, 2021

    SARS-CoV-2-specific Immunity in Individuals Who Have Recovered

    Active, not recruiting
    • SARS-CoV-2
    • COVID-19
    • Sample collection
    • Birmingham, Alabama
    • +52 more
    Sep 3, 2021

    The Covid-19 HEalth caRe wOrkErS (HEROES) Study

    Recruiting
    • Covid-19
    • +5 more
    • Exposure to the SARS-CoV-2 and its consequences
    • New York, New York
    • +21 more
    Mar 26, 2021

    COVID-19: Human Epidemiology and Response to SARS-CoV-2

    Completed
    • Coronavirus Disease 2019 (COVID-19)
    • SARS-CoV-2
    • Collection of Biological Samples
    • Symptom and Exposure Surveys
    • Aurora, Colorado
    • +19 more
    Feb 11, 2021

    COVID-19, COVID19, Sars-CoV2 Trial in New York (Hydroxychloroquine, Placebo)

    Withdrawn
    • COVID-19
    • +3 more
    • New York, New York
      Memorial Sloan - Kettering Cancer Center
    Oct 29, 2020